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The CD8+ memory T cell population is heteroge-
neous, and it is unclear which subset(s) optimally
mediate the central goal of the immune system—pro-
tection against infection. Here we investigate the
protective capacities of CD8+ T cell subsets present
at the memory stage of the immune response. We
show that a population of CD8+ T cells bearing
markers associated with effector cells (KLRG1hi,
CD27lo, T-bethi, Eomeslo) persisted to the memory
phase and provided optimal control of Listeria
monocytogenes and vaccinia virus, despite weak
recall proliferative responses. After antigen-specific
boosting, this population formed the predominant
secondary memory subset and maintained superior
pathogen control. The effector-like memory subset
displayed a distinct pattern of tissue distribution
and localization within the spleen, and their
enhanced capacity to eliminate Listeria involved
specialized utilization of cytolysis. Together, these
data suggest that long-lived effector CD8+ T cells
are optimal for protective immunity against certain
pathogens.
INTRODUCTION
During a typical immune response, antigen-specific CD8+
T cells undergo three characteristic phases: massive clonal
expansion, contraction of effector cells, and establishment of
memory. Considerable efforts have been made to define the
factors that control generation of short-lived effector cells and
establishment of long-lived memory (Jameson and Masopust,
2009; Kaech and Wherry, 2007; Masopust et al., 2007; Rutish-
auser and Kaech, 2010; Williams and Bevan, 2007). However,
the memory pool that is formed as the result of an immune
response is not homogeneous but rather contains distinct sub-
sets of cells that differ in their functional, proliferative, traf-
ficking, and survival characteristics (Jameson and Masopust,
2009; Seder et al., 2008). Some phenotypic features of memory
cells define their trafficking characteristics (e.g., CCR7 and
CD62L) or survival potential (e.g., the cytokine receptor chains
CD127 and CD122), whereas others are used as correlative
markers (such as the expression of KLRG1 on cells that are1250 Immunity 38, 1250–1260, June 27, 2013 ª2013 Elsevier Inc.typically thought to be senescent) (Hikono et al., 2007; Joshi
et al., 2007; Masopust et al., 2006a; Nolz et al., 2012; Sallusto
et al., 1999; Sallusto et al., 2004; Sarkar et al., 2008). The best
characterized division scheme for CD8+ memory T cells is the
paradigm of central and effector memory cells, based on
CD62L and CCR7 expression. Central memory T (Tcm) cells,
which express CD62L and CCR7, tend to localize to lymphoid
tissues and are capable of robust recall proliferation and inter-
leukin-2 (IL-2) production, whereas effector-memory T (Tem)
cells, characterized by lack of CD62L and CCR7 expression,
are prevalent at peripheral sites and can quickly become cyto-
lytic, yet exhibit more limited recall proliferation function (Bach-
mann et al., 2005a; Bachmann et al., 2005b; Seder et al., 2008;
Wherry et al., 2003; Wolint et al., 2004). Another division
scheme for CD8+ memory T cells was proposed by Hikono
et al., who used expression of CXCR3, CD27, and a glyco-
form of CD43 as a basis for subset identification (Hikono
et al., 2006). These markers subdivide the Tcm and Tem cell
pools, offering refinement of functional properties within the
memory-stage pool: for example, the CD27hiCD43lo subset
becomes dominant over time and shows optimal recall prolifer-
ation—and hence was presumed to be functionally superior
(Hikono et al., 2007).
These studies support the concept that the fully mature mem-
ory pool consists of long-lived CD8+ T cells with a CD62Lhi
CD27hi CD43lo KLRG1lo CD127hi phenotype, characterized by
efficient recall proliferation. However, such findings do not
necessarily mean that this population is optimal for immediate
protective immunity—the intended goal of vaccination. Indeed,
there is considerable controversy about which subset(s) of mem-
ory CD8+ T cells are most potent for pathogen control. For
example, in studies on CD8+ T cell control of vaccinia virus,
some groups proposed that Tcm cells are optimal for protection
(Laouar et al., 2008; Wherry et al., 2003), whereas others pro-
posed that Tem cells are the more potent subset (Bachmann
et al., 2005a; Bachmann et al., 2005b). There is better consensus
that Tcm cells, with their superior recall proliferative characteris-
tics, are best suited for control of LCMV (Bachmann et al., 2005a;
Bachmann et al., 2005b; Wherry et al., 2003) – but the mecha-
nisms involved in control of this noncytopathic virus may not
correspond to the responses needed to eliminate a pathogen
that causes direct tissue damage.
Implicit in these studies is the idea that cells with effector-like
properties—for example, cells with the KLRG1hi CD62Llo
CD27lo phenotype—play no role in protective immunity at the
memory stage. Initially, this conclusion seems reasonable
because effector cells are notable for their lack of recall
Figure 1. CD27lo CD43lo CD8+ Memory T Cells Display a Unique Phenotype
(A) Mice were infected with LCMV. One month after infection, splenocytes were stained for CD8+, gp33-Db tetramer, and the indicated markers. Data is
representative of at least four experiments (n = 12).
(B) Compiled data from experiments in which mice were infected with LCMV, LM-OVA, or LM-B8R. At the indicated time periods, antigen-specific cells were
identified (by using gp33-Db, Ova-Kb, or B8R-Kb tetramers, respectively) and the frequency of indicated subsets was determined. Data is compiled from at least
four experiments (n = 14 for 1–1.5 month period, n = 25 for 2–4 month period), presented as mean ± SEM.
(C) gp33-Db tetramer-binding CD8+ T cells from spleen and lymph nodes were stained with the indicated markers 1 month after infection with LCMV. Data is
representative of four experiments (n = 12). See also Figure S1.
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Protection by Effector-like Memory CD8+ T Cellsproliferation and susceptibility to death, leading to loss of most
effector-phenotype cells prior to the memory phase (Joshi
et al., 2007; Kaech et al., 2003; Prlic and Bevan, 2008; Sarkar
et al., 2008). Yet it is also notable that such studies find a small
subset of cells with effector-like traits that persists for many
months after a primary immune response. Furthermore, the
size and durability of CD8+ T cells with effector-like properties
is greatly enhanced following antigen-specific boosting of the
CD8+ T cell pool (Jabbari and Harty, 2006; Masopust et al.,
2006a; Sandau et al., 2010; Wirth et al., 2010b)—however, it
remains controversial whether production of such cells by
boosting enhances or diminishes the protective function of
CD8+ T cells (Hansen et al., 2009, 2011; Huster et al., 2009;
Jabbari and Harty, 2006; Nolz and Harty, 2011; Vezys et al.,
2009; Wirth et al., 2010b).
In the current report, we examine the functional significance
of cells with effector-like traits that persist to the memory
phase. By cell sorting, we show that memory-stage cells,
with a KLRG1hi, CD127int, CD27lo, CD62Llo phenotype, mediate
rapid protective immunity against infection with vaccinia virus
and Listeria monocytogenes, in spite of suboptimal recall prolif-
erative capacity. This population is expanded and maintained
long term following boosting, without losing their protective
superiority. This ‘‘long-lived effector’’ subset shows distinct
tissue localization (that can enhance encounter with pathogens)
and uniquely takes advantage of cytolytic capacity in its control
of Listeria. Together, these data suggest that immediate
protective immunity against acute pathogen infection is best
provided by cells with effector-like traits that persist to the
memory phase, suggesting a different focus for vaccination
strategies.RESULTS
Three Subsets of Memory Cells Defined by CD27 and
CD43 Expression Are Maintained Long Term after
Systemic Infection
Studies testing whether protective immunity is best mediated by
central or effector memory CD8+ T cells have led to contradictory
findings (Bachmann et al., 2005a, 2005b; Jameson and Maso-
pust, 2009; Laouar et al., 2008; Seder et al., 2008; Wherry
et al., 2003). Hence we investigated an alternative subsetting
system (based on expression of CD27 and an alternative glyco-
form of CD43), which was shown to accurately predict the
memory CD8+ T cell recall response (Hikono et al., 2007).We first
examined expression of these markers in antigen-specific CD8+
T cell populations persisting to thememory phase following a pri-
mary immune response against Listeria monocytogenes (LM) or
LCMV. In keeping with previous studies (Hikono et al., 2007;
Sandau et al., 2010), three main populations were observed:
CD27hi CD43lo, CD27hi CD43hi, and CD27lo CD43lo subsets (Fig-
ure 1A). These three populations arose following systemic infec-
tion with LCMV or LM recombinants (Figure 1B; see also
Figure S1A available online) and also developed after VV infec-
tion or LM delivered by the intranasal route (data not shown),
suggesting the type and route of acute infection does not influ-
ence the formation of such subsets. Likewise, similar subsets
were generated with priming of T cell receptor transgenic
CD8+ T cells (Figure S1B) (Sandau et al., 2010), indicating that
TCR affinity for antigen does not dictate differentiation into these
different memory stage subsets. As reported previously (Hikono
et al., 2007), the CD27hi CD43lo subset came to dominate the
memory pool at later time points, but all three populationsImmunity 38, 1250–1260, June 27, 2013 ª2013 Elsevier Inc. 1251
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immune response (Figure 1B).
Examination of other cell surfacemarkers revealed striking dif-
ferences between these subsets. CD27hi populations (whether
CD43hi or CD43lo) contained CD62Lhi and CD62lo subsets and
displayed markers of typical memory CD8+ T cells, including
high expression of the cytokine receptor chains CD122 and
CD127, with low expression of the ‘‘effector cell’’ marker,
KLRG1 (Figure 1C). Hence, prototypical Tcm and Tem cell pop-
ulations are both contained in the CD27hi subset. In contrast, the
CD27lo CD43lo pool showed a substantially different phenotype,
being CD127int and KLRG1hi. Furthermore, CD27lo CD43lo cells
exhibited high expression of the transcription factor T-bet but
minimal expression of the related factor Eomes, features which
are also associated with effector cells (Banerjee et al., 2010;
Intlekofer et al., 2005; Joshi et al., 2007). At first glance, this
phenotype suggests similarity between the CD27lo CD43lo sub-
set and short-lived effector cells (SLEC) (Joshi et al., 2007).
However, in contrast to the drastic downregulation of CD127
reported for short-lived effector cells (Joshi et al., 2007; Kaech
et al., 2003; Obar and Lefranc¸ois, 2010), the memory stage
CD27lo CD43lo population expressed CD127 at levels similar to
naive CD8+ T cells (albeit at lower levels than either CD27hi pop-
ulation) (Figure 1C; Figures S1C and S1D). Hence this population
is more similar to the KLRG-1, CD127 double-positive popula-
tion reported by others (Obar and Lefranc¸ois, 2010).
The CD27lo CD43lo Subset Shows Optimal Protection
against Listeria and Vaccinia Infection
Previous data suggest that the CD27lo CD43lo pool was poor at
recall proliferation (Hikono et al., 2007), and several phenotypic
features of this pool (high expression of KLRG1, low expression
of CD27, and CD127) have been correlated with senescent CD8+
T cells (Baars et al., 2005; Heffner and Fearon, 2007; Hikono
et al., 2007). Furthermore, this population (in contrast to the
CD27hi memory subsets) lacked expression of CXCR3 (Fig-
ure 1C), which might be expected to limit their ability to promptly
traffic to sites of inflammation. Hence, one might anticipate that
CD27lo CD43lo cells would show inferior protection compared to
the prototypical Tem and Tcm cell populations present in the
CD27hi pool. Yet this has not been directly tested. Thus, we
explored howCD27, CD43 defined subsets performed in protec-
tion assays by using aheterologous protectionmodel (Figure 2A).
Mice were primed with LCMV, memory populations were sorted,
and equivalent numbers of gp33-Db-specific CD8+ T cells from
each memory subset adoptively transferred into normal recipi-
ents. Host animals were infected with LM-gp33, and 5 days later
the donor cell expansion and LM clearance were determined.
Surprisingly, the CD27lo CD43lo subset provided significantly
greater protective immunity than either of the CD27hi memory
CD8+ T cell populations (Figure 2B). Interestingly, the enhanced
protection provided by the CD27lo CD43lo subset did not corre-
spond to the magnitude of the donor cell response during chal-
lenge—indeed, fewer donor cells were isolated from animals
receiving the CD27lo CD43lo pool (Figure 2C). This likely results
from less efficient adoptive transfer ‘‘take’’ of CD27lo CD43lo
cells initially (Figure S2A), together with reduced expansion of
this subsets after antigen encounter (in keeping with previous
studies [Hikono et al., 2007]). Regardless of mechanism, our1252 Immunity 38, 1250–1260, June 27, 2013 ª2013 Elsevier Inc.findings indicate that the size of the donor cell response did
not accurately predict LM elimination.
Similar results were observed when OT-I memory T cell sub-
sets were tested for protection against LM-OVA (Figure S2B),
ruling out potential differences in TCR affinity within the memory
subsets as a basis for distinct protective capacity. Also, studies
using titrated donor cell transfers indicated that low numbers of
the CD27lo CD43lo subset were more effective at protection than
an excess of CD27hi CD43lo or CD27hi CD43hi cells (Figure S2C).
Kinetic studies (using a homologous LM-OVA protection
assay) indicated that the CD27lo subset continued to reduce
the pathogen burden at day 7, outperforming both CD27 subsets
(Figure 2D). Whereas the CD27hiCD43lo population also offered
substantial immunity by day 7, CD27hiCD43hi cells were much
more variable inmediating LMclearance. None of the transferred
subsets were protective by the day 3 time point, indicating that
subsequent differences in donor-cell expansion did not relate
to differential early bacterial clearance. Together, these data
suggest that the CD27lo CD43lo subset offers the most potent
and efficient protective immunity. In contrast, the CD27hi sub-
sets (regardless of CD43 expression), offered considerably
weaker protective immunity, despite the fact that these subsets
include prototypical Tcm and Tem cell populations.
It was possible that optimal protection by the CD27lo CD43lo
memory pool was unique to assays involving LM control. There-
fore, we also investigated protective immunity against vaccinia
virus (VV), after priming with LM-B8R (a recombinant LM strain
bearing an immunodominant VV epitope). Furthermore, we
analyzed viral control in a nonlymphoid organ (the ovary, which
forms a site for intense VV replication (Karupiah et al., 1990))
rather than the spleen and liver analyzed for LM control. Again,
the CD27lo CD43lo population offered superior pathogen elimina-
tion, compared to the other memory subsets (Figure 2E). There-
fore, in diverse models of acute pathogen infection, CD27lo
CD43lo KLRG-1hi phenotype cells provide optimal protection,
compared to the classic memory phenotype CD8+ T cell pools.
Boosting Increases the Frequency of Protective CD27lo
CD43loKLRG1hi CD8+ Cells
Although the CD27lo CD43lo subset persists for many months
following priming (Figure 1), these cells eventually decline
(Hikono et al., 2007). Comparison between P14 memory CD8+
T cells at 1 month versus 1 year after priming demonstrated
almost complete loss of this subset in the ‘‘old’’ memory pool
(Figure S3A). Preliminary studies indicated that challenge of
these immunized mice resulted in efficient LM-gp33 control,
regardless of the time after priming (data not shown)—however,
because such animals have a large population of memory P14
CD8+ T cells (>5% of the CD8+ T cell pool), we further assayed
the protective function of ‘‘old’’ versus ‘‘young’’ P14 memory
cells by using adoptive transfer assays. Interestingly, agedmem-
ory P14 CD8+ T cells showed considerably weaker per-cell pro-
tection against LM-gp33 (Figure S3B). Although there may be
diverse reasons for this outcome, such results are consistent
with the CD27lo CD43lo subset offering superior control against
Listeria.
These findings raise the question of whether the size and
persistence of the CD27lo CD43lo subset can be extended. Inter-
estingly, previous work showed that antigen-specific boosting
Figure 2. Robust Protection by CD27lo CD43lo Memory Cells
(A) Experimental schematic. CD8+ CD44hi LCMV memory cells were sort purified 1–3 months after infection according to CD27 and CD43 expression, and each
population was injected into naive recipients, such that an equal number of gp33-Db tetramer-binding cells were adoptively transferred.
(B and C) Mice were challenged with LM-gp33. Five days after challenge, the number of CFU of LM in the spleen and liver was determined (B) and the number of
gp33-Db specific CD8+ T cells in the spleen quantified (C). Data are compiled from three independent experiments. Data in (B) shows individual CFU, with mean
values indicated by a line, while the data in (C) shows mean ± SD. p values are represented as follows: ***p < 0.001; **p < 0.01; *p < 0.05.
(D) Mice were primed with ActA LM-OVA, and at least 1 month later memory subsets were sorted and 3 3 104 cells of each subset adoptively transferred per
recipient. Host animals (and ‘‘No-transfer’’ controls) were infected with virulent LM-OVA and protection determined at 3, 5, or 7 days after infection. Data are
compiled from three experiments and shown as mean ± SEM. Statistical analysis is represented by asterisks, indicating significant changes in comparison with
the no-transfer group for each time point.
(E) A similar experimental plan to (A) was used, except thatmicewere infectedwith LM-B8R to induce aB8R-Kb specific response and, following transfer of sorted
memory CD8+ T cells, recipient mice were challenged with VV-WR. Three days after VV-WR infection, the number of PFU of VV in the ovaries was determined.
Individual mice compiled from three experiments are shown. See also Figure S2.
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within the antigen-specific CD8+ memory T cell pool (Masopust
et al., 2006a; Sandau et al., 2010; Wirth et al., 2010a, 2010b).
However, it was not clear whether these cells would show effi-
cient protective functions, because some studies suggest that
boosting decreases the fitness of CD8+ T cells and impairs their
ability to respond toward certain pathogens (Nolz and Harty,
2011; Wirth et al., 2010b).
To investigate this issue, we used an efficient prime-boost
strategy involving immunization with OVA peptide-coated cells,
followed by boosting with LM-OVA (Badovinac et al., 2005;
Pham et al., 2010). In such approaches, very few effector cells
are produced in the primary (1) response, with the vast majority
of antigen-specific cells rapidly adopting a central memory
phenotype (Badovinac et al., 2005; Pham et al., 2010) (data not
shown), and these memory cells quickly become competent toundergo an efficient secondary (2) response (Badovinac et al.,
2005; Pham et al., 2010). We selected this rapid prime-boost
system because it has been shown to induce potent 2CD8+
T cell memory, capable of protecting against viral, bacterial,
and parasitic infections (Pham et al., 2010). At least 3 months
after the last immunization, OVA-Kb-specific cells were
analyzed. Secondary memory cells showed a greatly expanded
population of CD27lo CD43lo cells, with few CD27hi CD43lo cells
(and virtually no CD27hi CD43hi cells) (Figures 3A and 3B), in
contrast to the diverse populations present in the 1 memory
CD8+ pool (which were analyzed in parallel, following immuniza-
tion with LM-OVA alone). The 2CD27lo CD43lo pool was even
moremarkedly reduced for expression of Eomes, but was similar
to its counterpart in the 1memory pool in being KLRG1hi T-bethi,
CD62lo and CXCR3lo, and CD127int (Figure 3C). Therefore,
boosting greatly enriches the frequency of the CD27lo CD43loImmunity 38, 1250–1260, June 27, 2013 ª2013 Elsevier Inc. 1253
Figure 3. CD27lo CD43lo Cells Are Strongly Increased with Boosting
(A) Example staining of the frequency of Kb-OVA+ cells expressing CD27 and CD43, 3–4 months after infection with ActA LM-OVA (primary memory) or 3–
4 months after boosting with LM-OVA (secondary memory). Data is representative of three experiments (n = 9).
(B) Compiled data of the frequency of CD27hi CD43lo and CD27lo CD43lo within Kb-OVA+ cells. Error bars show the average ± SD from three experiments (n = 9).
(C) MFI of phenotypic markers on primary and secondary memory populations. Naive (CD44lo) CD8+ T cells and/or B cells (CD19+) are also included for
comparison. Error bars show the mean ± SD from three experiments (n = 9). See also Figure S3.
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their major phenotypic features.
Next, we assessed the protective capacity of 2 memory sub-
sets, in comparison with cells from the 1 memory pool. The lack
of CD27hi CD43hi cells precluded assessment of this subset in
the 2 memory pool, and our studies on the 1 memory popula-
tion suggested similar protection by CD27hi CD43hi and CD27hi
CD43lo populations (Figure 2). Hence, we sorted CD27hi
CD43lo and CD27lo CD43lo subsets from 1 or 2 memory pools
and adoptively transferred these cells into normal recipients,
which were then challenged with virulent LM-OVA.
As expected, the 1 memory CD27lo CD43lo population dis-
played superior protective capacity compared to prototypical
memory cells (CD27hi CD43lo), and similar outcomes were
observed for the 2 memory subsets (Figure 4A). Once again,
efficient protection by the secondary memory CD27lo CD43lo
subset did not correlate with enhanced expansion of this popu-
lation (Figure 4B). Hence, these data suggest boosting expands
the number of CD27lo CD43lo memory CD8+ T cells without
eroding their protective capacity.1254 Immunity 38, 1250–1260, June 27, 2013 ª2013 Elsevier Inc.The CD27lo Memory CD8+ T Cell Subset Shows
Differential Tissue Localization and
Compartmentalization
Previous studies have shown that blood-borne LM initially
infects macrophages in the splenic red pulp and marginal
zone (Aoshi et al., 2009) and that initial memory CD8+ T cell
encounter with LM-infected cells might take place in the
red pulp (Baje´noff et al., 2010). Furthermore, short-lived effector
cells selectively occupy the red pulp (Jung et al., 2010). Hence,
we considered whether CD27lo CD43lo KLRG-1hi memory cells
showed preferential localization within the spleen. To analyze
this, we intravenously injected mice with fluorescent anti-CD8+
antibody and isolated tissues after a brief delay: This technique
labels CD8+ T cells exposed to the blood (including the splenic
red pulp) but does not label cells in tissue parenchyma (including
thewhite pulp) (Anderson et al., 2012; Galkina et al., 2005; Teijaro
et al., 2011). Interestingly, the CD27lo CD43lo pool was selec-
tively enriched in the red pulp, whereas the CD27hi CD43lo pop-
ulation showed preferential localization to the white pulp (Figures
5A and 5B). This asymmetry in red and white pulp distribution
Figure 4. Boosting Increases the Number of
Protective Memory Cells
CD27hi CD43lo and CD27lo CD43lo phenotype
memory CD8+ T cells were sorted from primary
and secondary memory mice 2.5–3.5 months after
the last antigen stimulation. Equal numbers of
OVA-Kb tetramer staining cells were transferred
into normal recipients, which were challenged with
LM-OVA 1 day later. Five days following LM-OVA
challenge, animals were sacrificed and (A) CFU of
LM was determined in the spleen.
(B) The expansion of donor CD27hi CD43lo and
CD27lo CD43lo secondary memory cells was
determined in the spleen 5 days after LM-OVA
challenge. The dotted line indicates the limit of
detection. Data are shown as mean ± SD and are
compiled from two independent experiments.
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(Figure S4), and hence might contribute to the differences in
protective immunity documented above. We also examined
the frequency of the CD27lo CD43lo population in other tissues.
Although this subset was 30%–40% of the splenic memory
pool (Figure 1B), it constituted around 75% of circulating
memory cells, yet was largely excluded from lymph nodes (as
expected from the lack of CD62L expression) (Figure 5C).
CD27lo memory cells constituted the vast majority of antigen-
specific cells in the small intestine IEL and LP compartments
(Figure 5C), as expected from earlier work (Masopust et al.,
2006b). These cells express CD43 (Masopust et al., 2006b)
(data not shown) and the extent of their similarity to CD27lo cells
in lymphoid tissues is not clear, but these findings support the
conclusion that localization of the CD27lo memory CD8+ T cell
pool is optimal for prompt engagement with invading pathogens.
Superior Protection against LM Depends on Cytolytic
Potential of the CD27lo CD43lo Subset
Recall expansion is frequently used as a parameter of memory
CD8+ T cell function and is often assumed to correspond to
potency in protective immunity. However, our data shows that
recall proliferation of primary and secondary memory CD8+
T cell subsets did not predict pathogen control (Figures 2
and 4). What then accounts for the enhanced protection medi-
ated by the CD27lo CD43lo pool? To address this, we first
assessed the ability of primary memory subsets to produce
inflammatory cytokines. Antigen induced production of inter-
feron-g (IFN-g) (Figure S5A) and tumor necrosis factor (TNF)
(data not shown) was similar for all three CD27, CD43 defined
subsets, assessed after cell sorting and in vitro activation with
specific peptide-MHC. This finding contrasts with a recent study
suggesting that CD27lo memory CD8+ T cells exhibit impaired
induction of IFN-g compared to CD27hi cells (Nolz et al., 2012)
but supports conclusions from earlier studies (Hikono et al.,
2007; Sandau et al., 2010). Memory CD8+ T cells can release
IFN-g in response to IL-12 and IL-18, and this may contribute
to pathogen clearance in a non-antigen-specific manner (Berg
et al., 2003; Kambayashi et al., 2003). However, that function
was also similar for all three subsets defined by using CD27
and CD43 (Figure S5B). We also considered that the CD27loCD43lo KLRG1hi subset may exhibit greater functional avidity
(i.e., sensitivity to low dose peptide-MHC ligand) (Slifka and
Whitton, 2001). However, when tested for upregulation of
CD69, IFN-g, and CD107a (a marker of degranulation), we
observed similar dose responses for KLRG1hi and KLRG1lo
memory subsets (Figure S5C).
Cytolytic ability is important for function of CD8+ T cells during
many infections—for example, Prf1/ memory CD8+ T cells
(lacking Perforin expression) are approximately five times less
active on a per cell basis in the clearance of LM (Messingham
et al., 2003). Previous studies reported that CD27lo CD43lo cells
(but not other memory subsets) express Granzyme B at steady
state (Hikono et al., 2007; Sandau et al., 2010), and we confirm
this finding (Figures 6A and 6B). However, the functional signifi-
cance of cytolysis has not been assessed in these memory sub-
sets. To evaluate this, we infected wild-type (WT) or Prf1/mice
with attenuated LM-OVA and, after memory differentiation,
sorted CD27, CD43 subsets (which developed similarly in both
types of mice; data not shown). Each subset was transferred at
equal number into WT mice followed by homologous challenge
with virulent LM-OVA, and protection wasmonitored 5 days after
infection. As expected, the CD27lo CD43lo memory subset iso-
lated from normal mice offered significantly better protection
than the other memory subsets (Figure 6C, left). However, this
protective advantage was completely lost when the CD27lo
CD43lo subset from Prf1/ animals was analyzed. Surprisingly,
this requirement for cytolytic potential was uniquely invested in
the CD27lo CD43lo population—Perforin deficiency did not
compromise the ability of either CD27hi subset to mediate partial
protection against LM infection (Figure 6C). This finding suggests
that cytolysis is critical for the ability of CD27lo CD43lo cells to
mediate rapid protection against LM, but also reveals that this
effector function is uniquely invested in the CD27lo CD43lo pool,
with the protective function of other memory subsets being Per-
forin independent. Such findings suggest specialized distribution
of key effector functions to certain memory CD8+ T cell subsets.
DISCUSSION
The goal of successful vaccination is rapid control of infection–
the timing of which could make the difference betweenImmunity 38, 1250–1260, June 27, 2013 ª2013 Elsevier Inc. 1255
Figure 5. CD27lo CD43lo Memory Cells Localize to the Red Pulp and Nonlymphoid Sites
(A) Discrimination of splenic red and white pulp by injection of anti-CD8+a antibody. CD27 and CD43 expression on gp33-Db tetramer-binding CD8+ T cells within
each compartment is shown, from mice infected 1–2 months earlier with LCMV. A representative example is displayed.
(B) Compiled data showing the localization of CD27hi CD43lo and CD27lo CD43lo memory CD8+ T cells, 1–2 months after LM-OVA or LCMV infection (gating on
OVA-Kb and gp33-Db tetramer-binding cells, respectively) (n = 13). The data represent mean ± SEM.
(C) The frequency of CD27hi or CD27lo antigen-specific memory CD8+ T cells in the blood, LN, IEL, and LPL compartments was determined, 1–2 months after
LCMV or LM-OVA infection. Error bars show compiled data from four experiments (n = 9) and are shown as mean ± SEM. See also Figure S4.
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Yet despite decades of work on memory T cell responses to
pathogens, surprisingly little is known about which memory
CD8+ T subsets mediate optimal protective immunity. In this
report, we focus on a memory CD8+ T cell subset that develops
during varied immune responses. The phenotypic traits of this
Tem subset (CD62Llo, CD27lo, KLRG-1hi, T-bethi, Eomeslo and
low CD127 expression) resemble those of short lived effector
cells, and this feature (together with the reduced long-term sur-
vival and weaker recall proliferation of this subset), has lead to
the conclusion that such cells may be senescent (Baars et al.,
2005; Heffner and Fearon, 2007; Hikono et al., 2007; Nolz
et al., 2012). Yet we found that this CD27lo CD43lo memory
subset provides themost robust resistance against certain acute
bacterial (Listeria) and viral (vaccinia) infections and demon-
strated that this protective population is expanded and main-
tained in the secondary memory pool (following rapid prime-
boost immunization).
Many studies use recall proliferation as an index for a ‘‘useful’’
memory T cell population, with the tacit assumption that rapid1256 Immunity 38, 1250–1260, June 27, 2013 ª2013 Elsevier Inc.production of numerous effector cells is a key element in control
of a rapidly replicating pathogen. However, our finding that the
CD27lo CD43lo memory CD8+ T cell pool excels at protection
despite displaying modest recall proliferation brings this correla-
tion into question. Rather than superior expansion, cytolytic po-
tential of the CD27lo CD43lo pool was critical for their enhanced
control of LM while, surprisingly, this function played little part in
themoremoderate protection mediated by CD27hi memory sub-
sets. Studies from Harty’s group showed that bulk Perforin-defi-
cientmemory CD8+ T cells displayed a reduced per-cell capacity
to control LM (Messingham et al., 2003): Our data suggest that
reliance on killing does not apply equally to all memory cell sub-
sets but rather reflects a selective utilization of cytolysis by the
highly protective CD27lo CD43lo population. Furthermore, the
CD27lo CD43lo memory pool showed preferential localization
to the red pulp of the spleen, which forms a major site for
encounter with blood-borne pathogens, including Listeria (Aoshi
et al., 2009) and is implicated as a key site for the initial encounter
of memory CD8+ T cells with LM-infected macrophages (Baje´n-
off et al., 2010). Previous studies found preferentially localization
Figure 6. Cytolytic Function Is Required for Enhanced Protective Immunity by CD27lo CD43lo Cells
(A) Intracellular staining of granzyme B by indicated memory subsets of gp33-Db tetramer-binding cells, 30 days after LCMV infection.
(B) Granzyme B expression in OVA-Kb tetramer-staining memory CD8+ T cell subsets isolated from animals immunized 3–4 months earlier with ActA LM-OVA.
Naive (CD44lo) CD8+ T cells are included as a control. Data are shown as mean ± SD (n = 9).
(C) Memory subsets were sorted from ActA LM-OVA infected B6 or Perforin-deficient (Prf1/) mice, 1–2 months after infection. Cells were transferred in equal
number into B6.SJL recipients, which were then challenged with LM-OVA. Five days after infection, the number of CFU in the spleen was calculated. Symbols
represent individual mice compiled from three different experiments. See also Figure S5.
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the red pulp (Jung et al., 2010): Our data extend those observa-
tions, demonstrating that the highly protective CD27lo CD43lo
memory CD8+ T cell subset is optimally placed to encounter
microbes in the blood. Such findings fit with the concept of
poly-functionality—in which optimally protective memory
T cells display multiple specialized traits (Seder et al., 2008)—
but do not exclude a model in which distinct pools of memory
T cells cooperate for protection. For example, in our studies
rapid pathogen control was mediated by CD27lo CD43lo cells,
yet the poor expansion of this subset suggests that progeny of
the CD27hi population will dominate in the recall effector
pool—the protective capacity of the CD27hi pool, although
delayed, may be essential for elimination of residual infection.
Our data tested protection against LM and VV—does the
CD27lo CD43lo long-lived effector pool mediate protection
against other pathogens? By using similar rapid prime-boost
approaches, Harty and colleagues showed that resistance to
Listeria, vaccinia, influenza, and malaria were all enhanced
(Badovinac et al., 2005; Pham et al., 2010): Those studies did
not define the full phenotype of the secondary memory popula-
tion, nor test protection by distinct memory subsets, but the pre-
dominance of CD27lo, CD43lo, KLRG-1hi, CD127int cells that we
detect in prime-boosted animals (Figure 3) suggests that these
cells are a likely source for protection in those studies. Alterna-
tively, it is likely that responses to some infectious agents will
involve distinct protection mechanisms, mediated by differentmemory subsets. For example, several studies indicate central
memory CD8+ T cells are best suited for control of LCMV (Bach-
mann et al., 2005a, 2005b; Nolz and Harty, 2011; Wherry et al.,
2003), and the superlative recall expansion of Tcm cell pool
may be critical for keeping pace with rapidly spreading virus. In
our hands, the CD62Lhi central-memory phenotype population
was exclusively found in the CD27hi memory CD8+ T cell subset,
and hence this pool may be key for responses that require effi-
cient lymph node entry (Nolz and Harty, 2011). Preliminary data
indicate that all three CD27, CD43 definedmemory subsets offer
similar, modest control of LCMV clone 13 infection (data not
shown), but further studies will be required to fully assess their
protective capacity compared to ‘‘classic’’ central memory
CD8+ T cells. Hence, our data should not be taken to mean
that CD27lo CD43lo are superior for control of all pathogen infec-
tions. Prior studies testing protection by bulk secondary memory
CD8+ T cells showed improved protection against LM and
vaccinia virus (in keeping with our findings on the elevated fre-
quency of the CD27lo CD43lo subset), but reduced control of
MHV and LCMV Clone 13 (Nolz and Harty, 2011). Hence, control
of different microbes may rely on the diversity of subsets within
the memory pool (especially following a primary immune
response). It will also be important to determine whether distinct
memory CD8+ T cell populations are optimal at control of sys-
temic versus local (e.g., mucosal) infections.
Nevertheless, our studies suggest production and preserva-
tion of CD27lo CD43lo cells will be useful as a vaccine goal forImmunity 38, 1250–1260, June 27, 2013 ª2013 Elsevier Inc. 1257
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effector cells, it has been proposed that CD27lo, KLRG1hi pheno-
type cells are a transient, senescent pool (Baars et al., 2005;
Heffner and Fearon, 2007; Hikono et al., 2007; Nolz et al.,
2012), although some studies reported that memory populations
enriched in cells of this phenotype survive and undergo recall
responses similarly to the CD27hi KLRG1lo pool (Prlic et al.,
2012). It is important to stress that, in contrast to short-lived
effectors, the CD27lo CD43lo KLRG1hi memory pool studied
here expresses CD127 (although at reduced levels compared
to CD27hi subsets) and CD122, cytokine receptor chains critical
for response to IL-7 and IL-15 respectively, and that this popula-
tion persists > 4 months after primary and secondary infections
(Figures 1 and 3). However, we did confirm that the CD27lo
CD43lo population declines considerably by 1 year after priming
and that this accompanies a loss in per-cell protective capacity
by the ‘‘aged’’ memory pool (Figure S3). Interestingly, recent
studies suggest that cells with an overlapping phenotype
(CD27lo CD62lo) constitute a death-intermediate pool of memory
cells, being an apoptosis-prone, nonfunctional population
derived from homeostasis of the central memory CD27hi subset
(Nolz et al., 2012). Also, some studies suggest ‘‘unhelped’’ mem-
ory CD8+ T cells (those primed in the absence of CD4 help)
display a related phenotype, and have impaired functional traits
(Edwards et al., 2013; Intlekofer et al., 2007). In contrast, our
studies indicate that the CD27lo population exhibits cytokine
production similar to CD27hi cells, undergoes recall proliferation
(albeit less efficiently than other memory subsets), and mediates
excellent protective function. Furthermore, the high frequency of
CD27lo CD43lo CD8+ T cells in the secondary memory pool
makes it unlikely that they are derived from rare central memory
cells in boosted animals. It will be important to determine
whether immunization strategies such as the rapid prime boost
approach employed here, affects the nature of CD27lo CD43lo
memory CD8+ T cell homeostasis.
In summary, our studies indicate that cells with effector-like
traits persist to the memory phase and constitute the most pro-
tective pool for control of certain infections. This subset shows
unique tissue localization and utilization of cytolysis in pathogen
control, and the fact that this subset is substantially expanded by




We purchased 6- to 12-week-old female C57BL/6 and B6.SJL mice from the
National Cancer Institute. TCR transgenic mice (P14 (Pircher et al., 1991)—a
kind gift of Dr. David Masopust, University of Minnesota, and OT-I (Hogquist
et al., 1994)—were maintained on a B6.PL (Thy-1.1) background. Perforin-
deficient mice were obtained from Jackson Laboratories and provided by
Dr. Stephen McSorely, University of California Davis. All mice were maintained
in SPF conditions, and all mouse protocols were approved by the University of
Minnesota Institutional Animal Care and Use Committee.
Bacterial and Viral Infections
Recombinant LM strains LM-OVA (virulent and ActA attenuated) and
LM-gp33 were provided by Hao Shen (University of Pennsylvania School
of Medicine, Philadelphia, PA) and John Harty (University of Iowa) and
have been described (Pope et al., 2001). In addition, a novel strain of virulent
LM-gp33 was kindly provided by Dr. Dietmar Zehn (University of Lausanne,1258 Immunity 38, 1250–1260, June 27, 2013 ª2013 Elsevier Inc.Switzerland). Attenuated strain LM-B8R (expressing the B8R CD8+ epitope
from vaccinia virus) (Hamilton et al., 2010) was provided by Dr. Ross Kedl
(National Jewish Medical Research Center, University of Colorado, Denver,
CO). LCMV (Armstrong) was provided by Dr. David Masopust (University of
Minnesota).
LM was grown in tryptic soy broth with 50 mg/ml streptomycin to an OD600
of 0.1. For LM-OVA challenges, 8 3 104 CFU were injected intravenously
(i.v.). For primary infection with attenuated LM-OVA or LM-B8R, 3–6 3 106
CFU were injected i.v. Primary infection with LCMV Armstrong was with
2 3 105 PFU injected intraperitoneally (i.p.). For challenge with vaccinia virus,
2 3 106 PFU of VV-WR was diluted in PBS and injected i.v. Secondary
memory cells were generated by immunization with OVA protein-coated
splenocytes followed by boosting with LM-OVA 1 week later (Pham et al.,
2010).
Flow Cytometry and Cell Sorting
For surface phenotype experiments, cells were stained with the following
antibodies from eBioscience or BD Biosciences unless otherwise noted:
CD8+ (53-6.7), CD44 (IM7), CD43 (glycoform sensitive antibody, 1B11; Bio-
legend), CD27 (LG.7F9), KLRG1 (2F1), CD62L (MEL-14), CD122 (TMb1),
CD127 (A7R34), and CXCR3 (CXCR3-173; Biolegend). The gp33-Db, OVA-Kb,
and B8R-Kb tetramers were generated as previously described (Daniels and
Jameson, 2000) or were provided by the NIH Tetramer Facility. For intracellular
staining, cells were fixed and permeabilized with Foxp3 Fixation and Permea-
bilization Buffers (eBioscience) and stained with antibodies to T-bet (4B10),
Eomesodermin (Dan11mag), and Granzyme B (MHGB04; Invitrogen) for 1 hr
at 4C in Permeabilization Solution. Flow cytometry data were analyzed by
using FlowJo analysis software. Intraepithelial and Lamina Propria cells of
the small intestine were isolated as previously described (Casey et al., 2012;
Masopust et al., 2010).
For cell sorting, spleen or spleen and lymph nodes were harvested from
mice >30 days after infection with LCMV or LM. Collagenase digestion was
performed on tissues followed by negative enrichment for CD8+ T cells by
using Miltenyi enrichment antibody cocktail and beads. Cells were then
stained with CD8+, CD44, CD27, and CD43 and sorted into populations by
using a FACSAria. Purity was confirmed and, where applicable, the number
of antigen-specific cells within each subset was determined by using tetramer
staining or analysis with relevant congenic markers. Next, 2–3 3 104 cells of
the indicated phenotype were injected (i.v.) into naive, congenically distinct
hosts, which were infected (as indicated) 1 day later.
Flow Cytometric Discrimination of Cells in Splenic White
and Red Pulp
As described (Anderson et al., 2012; Galkina et al., 2005; Teijaro et al., 2011),
micewere first injected i.v. with fluorescently labeled anti-CD8+a antibody. The
animals were sacrificed 3 min later, a splenocytes single-cell suspension was
prepared, and the cells were stained again for CD8+a, by using a distinct fluo-
rochrome conjugate, and simultaneously stained for other cell surface
markers. In some experiments, mice were perfused immediately after sacri-
fice, with similar findings. As shown by others (Anderson et al., 2012), cells
in contact with the blood circulation (including the splenic red pulp) are labeled
by the intravenously injected anti-CD8+ antibody, while cells in parenchymal
locations (including the splenic white pulp) are not.
In Vitro Stimulations
Sorted memory CD8+ T cells (P14 or OT-1) were incubated with peptide
(KAVYNFATM or SIINFEKL), and Brefeldin A (BD Biosciences) for 5 to 6 hr.
Following surface staining, cells were fixed and permeabilized with BD Cytofix
and Cytoperm (Becton Dickinson) followed by intracellular staining for IFN-g,
TNF, and IL-2 in BD Perm Wash Buffer (Becton Dickinson) (Hamilton et al.,
2006). Cytokine stimulations with IL-2, IL-12, and IL-18 were performed as
described previously (Haluszczak et al., 2009).
Determination of Colony-Forming Units and Cell Expansion
This was performed as previously described (Hamilton et al., 2006, 2010).
Briefly, on day 5 after infection, the spleen and liver were removed and placed
in a 0.2% IGEPAL solution (Sigma-Aldrich). Organs were homogenized, and
serial dilutions were plated onto TSB plates containing 50 mg/ml streptomycin.
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The limit of detection (approximately 100 organisms) is indicated on graphs by
a dashed line. To determine the number of transferred cells in recipient mice,
splenic single-cell suspensions were counted and stained with antibodies to
CD8+, CD44, and CD45.2 (104) or Thy1.1 (HIS51) (to identify donor cells)
and, in some cases, relevant peptide-MHC tetramer. In some experiments,
no-transfer control groups were used to determine the limit of donor cell
detection.
Plaque Assay
This was performed as previously described (Hamilton et al., 2010). Briefly, on
day 3 after infection with VV-WR, ovaries were harvested in PBS and frozen as
a single-cell suspension. After two freeze-thaw cycles, the ovary homogenate
was incubated at 37C for 45 min with 0.25 mg/ml trypsin (Sigma). 143B cells
(ATCC) were grown to confluence. Dilutions of the ovary homogenate were
added in duplicate to the cellular monolayer and left for two days. Staining
with 1% crystal violet was then performed. Plaques were counted and total
viral load per ovaries was calculated.
Statistics
A two-tailed, unpaired, Student’s t test was performed on log transformed
data, by using Prism (GraphPad Software). In some figures, p values are rep-
resented as follows: ***p < 0.001; **p < 0.01; *p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
article online at http://dx.doi.org/10.1016/j.immuni.2013.05.009.
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